Medrogestone is an orally active Progestin. Medrogestone shows a marked local progestational effect. Medrogestone maintains pregnancy in ovariectomized rats. Medrogestone inhibits ovulation. Medrogestone prevents pregnancy. Medrogestone produces a significant reduction in the severity of benign prostatic hypertrophy [1] [2].
References:
[1]. Revesz C, et al. Biological activity of medrogestone: a new orally active progestin. J Reprod Fertil. 1966 Dec;12(3):473-87.
[2]. Rangno RE, et al. Treatment of benign prostatic hypertrophy with medrogestone. Clin Pharmacol Ther. 1971 Jul-Aug;12(4):658-65.
References:
[1]. Revesz C, et al. Biological activity of medrogestone: a new orally active progestin. J Reprod Fertil. 1966 Dec;12(3):473-87.
[2]. Rangno RE, et al. Treatment of benign prostatic hypertrophy with medrogestone. Clin Pharmacol Ther. 1971 Jul-Aug;12(4):658-65.
















